U 96849
Alternative Names: U 96934; U 97018; U 97030Latest Information Update: 04 Feb 1998
Price :
$50 *
At a glance
- Originator Pharmacia Corporation
- Class Antihypertensives
- Mechanism of Action Angiotensin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension